European solar panel maker REC has struck back at a patent lawsuit filed by solar giant Hanwha QCELLS, saying it will petition the court to invalidate Hanwha’s patent for its passivation technology.
Leading solar panel manufacturer Hanwha Q CELLS has filed a lawsuit against Norway-based solar energy company REC Solar for allegedly infringing its patented solar technology, less than two weeks after filing similar cases against China-based competitors JinkoSolar and LONGi Solar.
The ACCC will announce in May whether it will approve the proposed $15 billion merger of telco giants TPG and Vodafone Hutchison Australia, after the parties’ failure to comply with requests for information caused the regulator to suspend its timeline last month.
Trial in a shareholder class action against engineering company WorleyParsons will be heard by a new judge in late August, six months after it was unexpectedly vacated.
A Sydney community group has lost a last-minute challenge to the demolition of Allianz Stadium, with the Court of Appeal throwing the case out in a unanimous decision.
The Commonwealth Bank of Australia has launched a bid to stay a shareholder class action brought by boutique law firm Phi Finney McDonald after the firm retreated from a plan to consolidate its case with a competing class action run by rival Maurice Blackburn.
Legal action brought by the corporate regulator over withheld documents at the centre of an investigation into AMP’s fees for no service conduct has settled, with law firm Clayton Utz producing the evidence on Thursday.
The NSW Land and Environment Court has shot down attempts to further delay demolition work as part of the $729 million redevelopment of Sydney’s Allianz Stadium.
The trial in a much anticipated shareholder class action against engineering firm WorleyParsons scheduled to commence this week has hit a roadblock, with a last minute change in the judge that will hear the matter.
German pharmaceutical company Boehringer has struck back at a patent lawsuit brought by Teva, filing a cross-claim alleging Teva is threatening to infringe three of its patents related to its blockbuster inhaler Spiriva with the planned launch of a competing inhaler in Australia.